Reference health

Genomic landscape and chronological reconstruction of driver events in multiple myeloma

1 of 34 checkable references need attention · checked 2026-07-23

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

References needing attention

does not resolve to a known work10.1038/leu.2017.344

The 33 checked references that resolve

resolves10.1182/blood-2014-10-567370

Genetics of multiple myeloma: another heterogeneity level?

resolves10.1038/nrclinonc.2016.122

Genomic complexity of multiple myeloma and its clinical implications

resolves10.1038/nrc3257

The genetic architecture of multiple myeloma

resolves10.1038/ncomms7997

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

resolves10.1038/ncomms3997

Heterogeneity of genomic evolution and mutational profiles in multiple myeloma

resolves10.1038/nature09837

Initial genome sequencing and analysis of multiple myeloma

resolves10.1016/j.ccr.2013.12.015

Widespread Genetic Heterogeneity in Multiple Myeloma: Implications for Targeted Therapy

resolves10.1200/JCO.2014.59.1503

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

resolves10.1182/blood-2012-01-405985

Clonal competition with alternating dominance in multiple myeloma

resolves10.1038/leu.2012.226

Minor clone provides a reservoir for relapse in multiple myeloma

resolves10.1038/leu.2013.199

Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms

resolves10.1038/leu.2017.345

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

resolves10.1038/bcj.2017.94

High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma

resolves10.1126/science.aab4082

Somatic mutation in cancer and normal cells

resolves10.1126/science.aaa6806

High burden and pervasive positive selection of somatic mutations in normal human skin

resolves10.1182/blood-2016-07-729954

Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma

resolves10.1016/j.celrep.2018.01.088

Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

resolves10.1038/nature14666

Non-coding recurrent mutations in chronic lymphocytic leukaemia

resolves10.1016/j.cell.2017.09.027

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

resolves10.1038/s41375-018-0103-3

Whole-genome sequencing of multiple myeloma reveals oncogenic pathways are targeted somatically through multiple mechanisms

resolves10.1101/181339

Patterns of structural variation in human cancer

resolves10.1016/j.cell.2013.02.023

Criteria for Inference of Chromothripsis in Cancer Genomes

resolves10.1038/nature13115

Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia

resolves10.1016/j.cell.2015.11.054

Chromothripsis and Kataegis Induced by Telomere Crisis

resolves10.1182/blood-2011-03-344069

Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients

resolves10.1001/jamaoncol.2015.2010

Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma

resolves10.1038/leu.2014.70

Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma

resolves10.1002/gcc.20123

Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses

resolves10.1038/bcj.2017.12

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker

resolves10.1101/161562

The evolutionary history of 2,658 cancers

resolves10.1038/s41467-017-00296-y

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

resolves10.1016/j.cell.2012.04.023

The Life History of 21 Breast Cancers

resolves10.1182/blood-2012-12-471888

Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells

What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1101/388611"><img src="https://citestamp.com/citestamped/10.1101/388611/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>

[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1101/388611/badge.svg)](https://citestamp.com/citestamped/10.1101/388611)